Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPersson, Camillaen
dc.contributor.authorCozier, Gylesen
dc.contributor.authorTrésaugues, Lionelen
dc.contributor.authorErneux, Christopheen
dc.contributor.authorNordlund, Pären
dc.contributor.authorMills, Stephen J.en
dc.contributor.authorThomas, Mark P.en
dc.contributor.authorRiley, Andrew M.en
dc.contributor.authorPotter, Barry V. L.en
dc.identifier.citationMills, S. J., Persson, C., Cozier, G., Thomas, M. P., Trésaugues, L., Erneux, C., et al. (2012). A Synthetic Polyphosphoinositide Headgroup Surrogate in Complex with SHIP2 Provides a Rationale for Drug Discovery. ACS Chemical Biology, 7(5), 822-828.en
dc.description.abstractPhosphoinositides regulate many cellular processes, and cellular levels are controlled by kinases and phosphatases. SHIP2 (SH2 (Src homology 2)-domain-containing inositol-phosphatase-2) plays a critical role in phosphoinositide signaling, cleaving the 5-phosphate from phosphatidylinositol 3,4,5-trisphosphate. SHIP2 is thought to be involved in type-2 diabetes and obesity, conditions that could therefore be open to pharmacological modulation of the enzyme. However, rational design of SHIP2 inhibitors has been limited by the absence of a high-resolution structure. Here, we present a 2.1 Å resolution crystal structure of the phosphatase domain of SHIP2 bound to the synthetic ligand biphenyl 2,3′,4,5′,6-pentakisphosphate (BiPh(2,3′,4,5′,6)P5). BiPh(2,3′,4,5′,6)P5 is not a SHIP2 substrate but inhibits Ins(1,3,4,5)P4 hydrolysis with an IC50 of 24.8 ± 3.0 μM, (Km for Ins(1,3,4,5)P4 is 215 ± 28 μM). Molecular dynamics simulations suggest that when BiPh(2,3′,4,5′,6)P5 binds to SHIP2, a flexible loop folds over and encloses the ligand. Compounds targeting such a closed conformation might therefore deliver SHIP2-specific drugs.en
dc.relation.ispartofseriesACS chemical biologyen
dc.rights© 2012 American chemical society.en
dc.subjectDRNTU::Science::Biological sciencesen
dc.titleA synthetic polyphosphoinositide headgroup surrogate in complex with SHIP2 provides a rationale for drug discoveryen
dc.typeJournal Articleen
dc.contributor.schoolSchool of Biological Sciencesen
item.fulltextNo Fulltext-
Appears in Collections:SBS Journal Articles

Google ScholarTM



Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.